| Surrogate Trials (N=138) N(%) | Final Trials (N=132) N(%) |
---|---|---|
Intervention clinical area | Â | Â |
Cardiovascular | 31(22) | 31(23) |
Endocrinology | 11(8) | 4(3) |
Gastrology/hepatology | 11(8) | 11(8) |
Infectious disease | 28(20) | 28(21) |
Nephrology/urology | 4(3) | 4(3) |
Neurology | 2(1) | 3(2) |
Obstetrics | 5(4) | 5(4) |
Oncology | 4(3) | 4(3) |
Other | 36(26) | 36(27) |
Pulmunology | 6(4) | 6(5) |
Population clinical area | Â | Â |
Cardiovascular | 34(25) | 31(23) |
Endocrinology | 14(10) | 9(7) |
Gastrology/hepatology | 9(7) | 10(8) |
Infectious disease | 21(15) | 21(16) |
Nephrology/urology | 2(1) | 5(4) |
Neurology | 2(1) | 2(2) |
Obstetrics | 7(5) | 8(6) |
Oncology | 4(3) | 4(3) |
Other | 36(26) | 36(27) |
Pulmunology | 9(7) | 6(5) |
Journal | Â | Â |
Annals | 14(10) | 10(8) |
BMJ | 11(8) | 14(11) |
JAMA | 31(22) | 31(23) |
Lancet | 28(20) | 28(21) |
NEJM | 51(37) | 49(37) |
PLoS | 3(2) | - |
Year | Â | Â |
2005 | 64(46) | 63(48) |
2006 | 74(54) | 69(52) |